Skip to main content
. 2017 Mar;74:38–46. doi: 10.1016/j.ejca.2016.11.031

Table 3.

Surgery.

OxCapRT
CarPacRT
n % n %
Patients randomised 42 43
Patients not having surgery, n (%) 6 14.3 2 4.7
 Disease progression 3 7.1 1 2.3
 Comorbidity 1 2.4 0 0.0
 Died before surgery 2 4.8 1 2.3
Patients having surgery 36 85.7 41 95.3
Days between finishing pre-surgical treatment and surgery, median (n, IQR, range) 52 (36, 47–64,37–92) 56 (41, 49–73,41–147)
Number of days in hospital post-surgery as an in-patient (d), median (n, IQR, range) 11.5 (36, 9.5–16, 0–74) 12 (40, 10–19,0–67)
30-d post-operative mortality 1a 2.8 1b 2.4
30-d post-operative complicationsc Any complication 19 54.3 21 51.2
Respiratory complications 14 40.0 15 36.6
Cardiac complications 9 25.7 4 9.8
Wound infection 3 8.6 5 12.2
Chylothorax requiring treatment 1 2.9 2 4.9
Haemorrhage requiring transfusion or intervention 2 5.7 0 0.0
Other complications 9 25.7 9 22.0
Anastomotic leak None 32 88.9 35 85.4
Radiological/endoscopic 0 0.0 3 7.3
Missing data 4 11.1 3 7.3
a

Multiple organ failure following cardiac arrest. Hospital acquired pneumonia following surgery. Adenocarcinoma of oesophagus.

b

Anastomotic leak.

c

Uses a denominator of 35 in the OXCAP-CRT arm—one patient has missing complications data.